Skip to main content
. 2022 Sep 16;14(9):1961. doi: 10.3390/pharmaceutics14091961

Figure 12.

Figure 12

Assessment of diosmin effect on ARPE-19 cell viability (*** p < 0.0005, ** p < 0.005 vs. CTRL).